FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner. Pifer PM, Yang L, Kumar M, Xie T, et al. Clin Cancer Res 2023 Oct 11. doi: 10.1158/1078-0432.CCR-23-0964.

Read + Share

Amedeo Smart

Independent Medical Education

Pifer PM, Yang L, Kumar M, Xie T, et al. FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner. Clin Cancer Res 2023 Oct 11. doi: 10.1158/1078-0432.CCR-23-0964.
PMID: 37819945